Liver Cancer- Need to Know

Share Button

Liver Cancer – Need To Know- A diagnosis of liver cancer can be overwhelming. Liver cancer — most commonly hepatocellular carcinoma (HCC)— is a serious disease that arises when abnormal cells in the liver grow uncontrollably. Understanding risk factors, symptoms, standard treatments, and potential supportive strategies can help patients and caregivers make informed decisions.

If you or someone you love has been diagnosed with liver cancer, understanding the disease, treatment options, and supportive therapies can help you make informed decisions and improve outcomes.

This post explains the essentials of liver cancer and highlights evidence-based integrative therapies that may improve treatment tolerance, immune function, and survivorship.

Be sure to watch each of the videos about:

  1. Gut Microbiome Health
  2. Prehabilitation
  3. Intravenous Vitamin C therapy

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about liver cancer.

Good luck,

David Emerson

• Cancer Survivor
• Cancer Coach
• Director PeopleBeatingCancer


What Is Liver Cancer?

“Liver cancer” refers to malignant tumors that originate in liver tissue. The most common type is hepatocellular carcinoma (HCC), accounting for about 80–90% of cases worldwide. HCC often develops in the setting of chronic liver disease such as hepatitis B or C infection, alcohol-related liver damage, or metabolic liver disease.


Liver Cancer by the Numbers

  • HCC is the sixth most common cancer worldwide and among the leading causes of cancer death.
  • Chronic viral hepatitis (B and C) and metabolic dysfunction-associated steatotic liver disease (MASLD) are major contributors to global liver cancer burden.

Risk Factors

Key risk factors for liver cancer include:

  • Chronic hepatitis B or C infection – leading cause globally.
  • Excessive alcohol use, cirrhosis, and metabolic liver disease (including MASLD).
  • Obesity and diabetes, which contribute to fatty liver disease and HCC risk.

Signs & Symptoms

Early liver cancers often don’t cause symptoms. As the disease progresses, patients may notice:

  • Unexplained weight loss
  • Abdominal pain or swelling
  • Jaundice (yellowing of skin/eyes)
  • Loss of appetite

Because these signs can overlap with other liver conditions, careful evaluation by a specialist is critical.


Diagnosis

Liver cancer is typically diagnosed through:

  • Imaging studies such as ultrasound, CT, or MRI
  • Blood tests including alpha-fetoprotein (AFP)
  • Biopsy when needed for definitive diagnosis

Standard Treatment Options

Treatment depends on tumor size, number, liver function, and patient health:

  • Surgery (resection) — removal of the tumor when feasible.
  • Liver transplantation — an option for selected patients with early HCC.
  • Transarterial chemoembolization (TACE) — used for intermediate or inoperable tumors.
  • Systemic therapies, including targeted therapies and immunotherapy.

For more on global clinical practice guidelines, see Hepatocellular carcinoma: ESMO Clinical Practice Guideline (Ann Oncol. 2025).


Emerging Supportive Research

Some recent studies suggest lifestyle modifications may influence liver cancer risk or progression:

  • Diet matters: A review in Nutrition Reviews found diets rich in fiber, omega-3s, and plant foods were associated with lower liver cancer risk.
  • Prevention-focused strategies: A major Lancet Commission analysis suggests that up to ~60% of liver cancer cases could be prevented with hepatitis vaccination, reduced alcohol use, and metabolic disease management.

Supportive & Integrative Considerations

While not replacements for standard therapy, evidence-informed strategies may support overall health and treatment tolerance:

  • Nutrition and weight management: Support metabolic health and potentially reduce risk of disease progression.
  • Exercise and physical activity: Maintain strength and mitigate fatigue.
  • Psychological support: Counseling, support groups, or stress-management techniques.

Always discuss integrative therapies with your oncology team.


Liver Cancer — Nutritional Supplements

Before you start

Because the liver processes many drugs and supplements, always clear supplements with your oncology/hepatology team, especially if you have cirrhosis, portal hypertension, or are receiving immunotherapy or targeted therapy.

Supplements with the best human supportive evidence (adjuncts, not cures)

  • Omega-3 fatty acids (fish oil; EPA/DHA)
    Why it may help: In a randomized study in hepatectomy patients with HBV-associated HCC, omega-3–supplemented nutrition was associated with fewer infections and better short-term liver function recoveryafter surgery.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/23554777/
    Safety notes: Can increase bleeding risk in some settings; discuss before surgery or if on anticoagulants/antiplatelets.

“Promising but not proven” (mostly preclinical / early-stage evidence)

  • Curcumin (turmeric extract)
    Why it’s discussed: Mechanistic and preclinical work suggests anti-inflammatory/anti-proliferative activity in HCC models, but well-powered human trials in HCC are still lacking (and formulation/bioavailability matters).
    PubMed (review): https://pubmed.ncbi.nlm.nih.gov/41044771/
    Safety notes: Can interact with anticoagulants and some chemotherapy metabolism pathways; GI upset is common at higher doses.

 

  • Milk thistle (silymarin)
    Why it’s discussed: Widely used for “liver support.” Evidence specific to treating HCC in humans is not established; much of the literature is preclinical or mechanistic.
    PubMed (systematic review of preclinical data): https://pubmed.ncbi.nlm.nih.gov/25603021/
    Safety notes: “Liver detox” products can be contaminated or hepatotoxic; use only reputable brands and discuss with your clinician.

Practical “supplement strategy” for many HCC patients

  • Focus first on correcting documented deficiencies (e.g., vitamin D, zinc, etc.) based on labs and your care team’s guidance—especially important in chronic liver disease.
  • Avoid high-dose “stacks” during active treatment unless supervised.

Intravenous Vitamin C (IVC)

High-dose IV vitamin C achieves pharmacologic plasma levels not possible orally.

Proposed mechanisms:

  • Pro-oxidant effects in tumor cells
  • Enhanced chemotherapy sensitivity
  • Reduction in treatment-related fatigue

Early phase trials in glioblastoma show safety and potential synergy with radiation.

Reference:
Ma Y, et al. Redox Biology. 2014.
https://pubmed.ncbi.nlm.nih.gov/24993823/

Important: Should only be administered under supervision of an experienced integrative oncology provider.



Prehabilitation and Liver Cancer-

https://pmc.ncbi.nlm.nih.gov/articles/PMC12554228/


Gut Microbiome & Liver Cancer

Emerging research suggests:

  • The gut microbiome influences immune response
  • Microbiome composition may affect immunotherapy outcomes
  • Antibiotic exposure may negatively impact treatment response

Reference:

https://pmc.ncbi.nlm.nih.gov/articles/PMC10168020/

Supportive strategies include:

  • High-fiber plant foods
  • Fermented foods
  • Avoid unnecessary antibiotics
  • Discuss probiotic use with an oncologist


References

Liver Cancer – Need To Know Liver Cancer – Need To Know Liver Cancer – Need To Know

Leave a Comment: